Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-21-021441
Filing Date
2021-06-01
Accepted
2021-06-01 21:14:55
Documents
2
Period of Report
2021-06-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2260
2 EX-24 DOCUMENT attachment1.htm EX-24 3919
  Complete submission text file 0000899243-21-021441.txt   7622
Mailing Address C/O FLEXION THERAPEUTICS, INC. 10 MALL ROAD, SUITE 301 BURLINGTON MA 01803
Business Address
Arkowitz David (Reporting) CIK: 0001296999 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37465 | Film No.: 21987438

Mailing Address 200 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 200 SIDNEY STREET CAMBRIDGE MA 02139 617 945 9626
Seres Therapeutics, Inc. (Issuer) CIK: 0001609809 (see all company filings)

EIN.: 274326290 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations